52 results
SC TO-T/A
EX-99
Concentra Merger Sub II, Inc.
14 Feb 24
Third party tender offer statement (amended)
10:35am
transferred CVRs registered in the CVR Register will be the valid obligations of Purchaser and will entitle the transferee to the same benefits and rights … attempted assignment of this Agreement or any such rights in violation of this Section 6.3 shall be void and of no effect.
Section 6.4 Benefits
SC TO-T/A
THRX
Theseus Pharmaceuticals Inc
7 Feb 24
Third party tender offer statement (amended)
5:15pm
) demonstrate the actual and perceived benefits of any product related to the CVR Products, if approved, relative to existing and future alternative
SC TO-T/A
EX-99
THRX
Theseus Pharmaceuticals Inc
30 Jan 24
Third party tender offer statement (amended)
8:23am
) demonstrate the necessary safety data post-approval to ensure continued regulatory approval, (viii) demonstrate the actual and perceived benefits of any … or accelerate any rights or benefits under any Theseus benefit plan or benefit agreement or (G) hire or terminate (other than for cause) the employment
SC 14D9
THRX
Theseus Pharmaceuticals Inc
10 Jan 24
Tender offer solicitation
9:47am
at the Effective Time;
The potential receipt of severance payments and benefits by current and former executive officers under their respective employment … , entitling each such executive officer to certain severance and change of control benefits (if applicable). The Merger, if and when consummated
SC TO-T
EX-99
THRX
Theseus Pharmaceuticals Inc
10 Jan 24
Third party tender offer statement
8:51am
to ensure continued regulatory approval, (viii) demonstrate the actual and perceived benefits of any product related to the CVR Products, if approved … or benefits under any Theseus benefit plan or benefit agreement or (G) hire or terminate (other than for cause) the employment or service of any employee
SC TO-T
EX-99
nzsz391jay t4w1nznsa
10 Jan 24
Third party tender offer statement
8:51am
SC TO-T
EX-99
2ivzqurz5p65kn
10 Jan 24
Third party tender offer statement
8:51am
SC TO-T
EX-99
bex3q8x frlu
10 Jan 24
Third party tender offer statement
8:51am
8-K
EX-2.1
tykg5ufx
22 Dec 23
Entry into a Material Definitive Agreement
6:36am
8-K
EX-10.1
u7h6l1
4 Dec 23
Departure of Directors or Certain Officers
6:30am
8-K
EX-10.3
i2d4wp
4 Dec 23
Departure of Directors or Certain Officers
6:30am
8-K
EX-10.2
n27e6gqkgp
13 Nov 23
Theseus Pharmaceuticals Announces Process to Explore Strategic Alternatives
4:06pm
8-K
u7o ehfl2wpfm1lso0
13 Nov 23
Theseus Pharmaceuticals Announces Process to Explore Strategic Alternatives
4:06pm
PRE 14A
bxbfpej
14 Apr 23
Preliminary proxy
9:00am
S-3
EX-1.2
chg4jbd3pvg9bh8ys7ri
3 Nov 22
Shelf registration
9:06am